Mostly, the upregulation of EPH receptors leads to tumor-promoting functions in bone sarcomas such as tumor cells migration and proliferation by EPHA2, along with enhanced carcinogenesis and invasion by EPHA7 in osteosarcoma. The gene discussed is EPHA2; the disease is neoplasm.